The Effect of Exercise on Physical Function in Older Women With Osteoporosis and a History of Vertebral Fracture
- Conditions
- Vertebral FracturesOsteoporosis
- Interventions
- Other: Exercise
- Registration Number
- NCT02781974
- Lead Sponsor
- Oslo Metropolitan University
- Brief Summary
The study is a parallel-group single blinded randomized controlled trial, examining the effect of exercise on physical function in older women with osteoporosis and a history of vertebral fracture. The participants will randomly be assigned in a 1:1 ratio to the intervention group and the control group. The intervention will follow newly developed exercise recommendations for people with osteoporosis and vertebral fractures, which states the balance- and strength exercises should be performed at least twice a week. The intervention is a group exercise session circuit program lasting for 12 weeks. The participants will be tested at baseline, and followed up at 3 months and 6 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 149
- Women over 65 years, living at home, able to walk with or without walking aids
- having osteoporosis verified by DXA scan (-2,5)
- at least one vertebral fracture, verified by X-ray
- Health conditions that make it unsafe to exercise
- not able to understand and speak Norwegian adequately to participate in the intervention
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Exercise Intervention consists of strength and balance exercise in group sessions, twice a week for 12 weeks
- Primary Outcome Measures
Name Time Method 10 meter habitual walking speed Up to 18 months
- Secondary Outcome Measures
Name Time Method Senior Fitness test Up to 18 months Functional reach Up to 18 months Grip Strength Up to 18 months Quality of life of participants assessed by the questionnaire Qualeffo 41 Up to 18 months Four Square Step Test Up to 18 months Short Form -36 Up to 18 months FES-1 Up to 18 months IPAQ-SF Up to 18 months Patient Specific Function Scale Up to 18 months
Trial Locations
- Locations (1)
OsloMet - Oslo Metropolitan University
🇳🇴Oslo, Norway